Charles Kummeth

2020

In 2020, Charles Kummeth earned a total compensation of $11.5M as President and CEO at Bio-Techne, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,767,957
Option Awards$4,310,748
Salary$1,053,000
Stock Awards$4,310,652
Other$41,425
Total$11,483,782

Kummeth received $4.3M in option awards, accounting for 38% of the total pay in 2020.

Kummeth also received $1.8M in non-equity incentive plan, $1.1M in salary, $4.3M in stock awards and $41.4K in other compensation.

Rankings

In 2020, Charles Kummeth's compensation ranked 670th out of 13,090 executives tracked by ExecPay. In other words, Kummeth earned more than 94.9% of executives.

ClassificationRankingPercentile
All
670
out of 13,090
95th
Division
Manufacturing
232
out of 5,621
96th
Major group
Chemicals And Allied Products
75
out of 2,254
97th
Industry group
Drugs
64
out of 1,954
97th
Industry
Biological Products, Except Diagnostic Substances
17
out of 411
96th
Source: SEC filing on September 14, 2022.

Kummeth's colleagues

We found four more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2020.

2020

James Hippel

Bio-Techne

Chief Financial Officer

2020

David Eansor

Bio-Techne

Former President, Protein Sciences

2020

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

2020

Brenda Furlow

Bio-Techne

General Counsel

News

You may also like